References
- Heinemann K, Reed S, Moehner S, et al. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for intrauterine devices. Contraception. 2015;91:280–283.
- Suvisaari J, Lahteenmaki P. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception. 1996;54:201–208.
- Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. BJOG. 1990;97:690–694.
- Gemzell-Danielsson K, Apter D, Dermout S. Corrigendum to “Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use”. Eur J Obstet Gynecol Reprod Biol. 2019;233:164–128. Erratum 2019;233:164–165.
- Nelson AL. LNG-IUS 12: a 19.5 levonorgestrel-releasing intrauterine system for prevention of pregnancy for up to five years. Expert Opin Drug Deliv. 2017;14:1131–1140.
- Jensen J, Mansour D, Lukkari-Lax E, et al. Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies. Contraception. 2013;87:107–112.
- Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril. 2012;97:616–622.
- Diedrich JT, Desai S, Zhao Q, et al. Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. Am J Obstet Gynecol. 2015;212:50.e1–50.
- Schmidt EO, James A, Curran KM, et al. Adolescent experiences with intrauterine devices: a qualitative study. J Adolesc Health. 2015;57:381–386.
- Mansour D. International survey to assess women’s attitudes regarding choice of daily versus nondaily female hormonal contraception. Int J Women's Health. 2014;6:367–375.
- Nappi R, Kaunitz A, Bitzer J. Extended regimen combined oral contraception: a review of evolving concepts and acceptance by women and clinicians. Eur J Contracept Reprod Health Care. 2016;21:106–115.
- Edelman A, Micks E, Gallo MF, et al. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev. 2014;7:CD004695.
- Merki-Feld GS, Caetano C, Porz TC, et al. Are there unmet needs in contraceptive counselling and choice? Findings of the European TANCO study. Eur J Contracept Reprod Health Care. 2018;23:183–193.
- Birgisson NE, Zhao Q, Secura GM, et al. Preventing unintended pregnancy: the contraceptive CHOICE project in review. J Women's Health. 2015;24:349–353.
- Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception. 1986;34:253–260.
- Fraser IS, Critchley HO, Broder M, et al. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Fertil Steril. 2011;95:2204–2208.
- Gerlinger C, Endrikat J, Kallischnigg G, et al. Evaluation of menstrual bleeding patterns: a new proposal for a universal guideline based on the analysis of more than 4500 bleeding diaries. Eur J Contracept Reprod Health Care. 2007;12:203–211.
- Peipert JF, Zhao Q, Allsworth JE, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117:1105–1113.
- Bayer AG. Kyleena (levonorgestrel-releasing intrauterine system). Prescribing Information 2016.
- Fraser IS, Langham S, Uhl-Hochgraeber K. Health-related quality of life and economic burden of abnormal uterine bleeding. Expert Rev Obstet Gynecol. 2009;4:179–189.
- Schreiber CA, Teal SB, Blumenthal PD, et al. Bleeding patterns for the Liletta levonorgestrel 52 mg intrauterine system. Eur J Contracept Reprod Health Care. 2018;23:116–120.